Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Bloom Burton & Co.

Investor type Venture Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 18
Average round size
info
The average size of a deal this fund participated in
$39M
Portfolio companies 13
Rounds per year 1.38
Lead investments 5
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.28
Exits 11
Key employees Soon

Areas of investment

  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
  • Therapeutics
Summary

In 2008 was created Bloom Burton & Co., which is appeared as Corporate Investor. The main office of represented Corporate Investor is situated in the Toronto. The venture was found in North America in Canada.

The fund is constantly included in less than 2 deals per year. The top activity for fund was in 2014. The higher amount of exits for fund were in 2015. This Bloom Burton & Co. works on 31 percentage points more the average amount of lead investments comparing to the other organizations. The real fund results show that this Corporate Investor is 0 percentage points less often commits exit comparing to other companies. The usual things for fund are deals in the range of 10 - 50 millions dollars.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Bloom Burton & Co., startups are often financed by MaRS Investment Accelerator Fund, Jeff Chapleau, Genesys Venture. The meaningful sponsors for the fund in investment in the same round are GMP Securities, Cormark Securities Inc., RBC Capital Markets.

The fund has exact preference in a number of founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Canada. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Medical Device, Wellness. Among the most popular portfolio startups of the fund, we may highlight Knight Therapeutics, Profound Medical Inc, Newtopia.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Bloom Burton & Co.:
Typical Co-investors
Bloom Burton & Co. is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Bloom Burton & Co.:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
5 Continents Consulting Group Basel-Stadt, Binningen, Switzerland
Alpha Animation China, Guangdong, Guangzhou
Bedrock Venture Management Delhi, Delhi, India
Caffeinated Capital California, San Francisco, United States
Clear Future Herzliya, Israel, Tel Aviv
FoundersPad Bend, Oregon, United States
Future Invest China, Hangzhou, Zhejiang
Harmony Medical -
HBS Alumni Angels New York New York, New York, United States
Jerry Pruttz Holding Ab -
Leo Partners Investment Seoul, Seoul-t'ukpyolsi, South Korea
Liberty Financial Australia, Melbourne, Victoria
Ofir Technologies -
Ookbee Bangkok, Krung Thep, Thailand
PacVen Walden Ventures China, Hong Kong, Hong Kong Island
Reliance Modal Ventura -
SeedStep Angels Oklahoma, Tulsa, United States
Trends Media -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

AceAge

Health Care
Home Health Care
Medical Device
$3M03 Dec 2020 Ontario

Triumvira Immunologics

Biotechnology
Clinical Trials
Health Care
$55M27 Aug 2020 Austin, Texas, United States

Appili Therapeutics

Biotechnology
Health Care
Therapeutics
$13M10 Jun 2020 Halifax, Nova Scotia, Canada

Antibe Therapeutics

Biotechnology
Medical
Therapeutics
$22M09 Jun 2020 Canada, Ontario

HLS Therapeutics

Biotechnology
Medical
Pharmaceutical
$39M14 May 2019 Canada, Ontario

Hamilton Thorne

Biotechnology
Fertility
Hardware
$7M28 Aug 2018 Beverly, Massachusetts, United States

Bellus Health

Biotechnology
Clinical Trials
Health Care
Wellness
$15M12 Dec 2017 Quebec

Knight Therapeutics

Biotechnology
Medical
Pharmaceutical
$79M22 Dec 2016 Quebec

Newtopia

B2B
Gamification
Genetics
Health Care
$10M18 Oct 2016 Ontario

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Bloom Burton & Co.?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: